IPO Date: Sep 1 to Sep 3 2025
Listing Date: Sep 9 2025
1. Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat;
2. Funding capital expenditure requirements towards purchase of equipment, plant and machinery for setting up new manufacturing line for Small Volume Parenteral (“SVP”) at Hariyala, Kheda, Gujarat; and
3. General corporate purposes.
...
oducts, being packed in plastic container with Aseptic Blow-Fill-Seal (“ABFS”)and Injection Strech Blow Moulding (“ISBM”) technology. Parenteral products can be useful in cases wherepatients cannot intake drug through oral route or drugs are not suitable for oral intake. Additionally, these productsallow rapid absorption of the drug, thereby providing fast action. Furthermore, parenteral routes are better suitedfor drugs which have poor absorption in the gastrointestinal tract or are destroyed by digestive secretions. (Source:CRISIL Report) We manufacture large volume parenterals (“LVPs”) and small volume parenterals (“SVPs”) insix therapeutic segments. In addition to that, we also manufacturer medical devices. We manufacture fluid therapy- (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segmentand products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. We offer wide rangeof closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume rangingfrom 2ml to 1000 ml. Read MoreMUFG Intime India Pvt Ltd.
Posted on Dec 19th
Zensar Technologies informs about press release
Posted on Dec 19th
Admach Systems coming with IPO to raise Rs 42.60 crore
Posted on Dec 19th
Winter session of Parliament ends, both Houses adjourned sine die
Posted on Dec 19th
Currency futures for December expiry trade stronger with 0.24% increase in OI
The issue size of Amanta Healthcare Ltd. IPO is ₹84.00 - 88.20 crore.
The Amanta Healthcare Ltd. IPO opens for subscription on 2025-09-01 and closes on 2025-09-03.
The price range of Amanta Healthcare Ltd. IPO is ₹120.00 to ₹126.00.
The lot size of Amanta Healthcare Ltd. IPO is 119 shares.
The registrar of Amanta Healthcare Ltd. IPO is MUFG Intime India Pvt Ltd..
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.